Skip to search boxSkip to navigationSkip to main content

Dibucaine mitigates spreading depolarization in human neocortical slices and prevents acute dendritic injury in the ischemic rodent neocortex

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

Background: Spreading depolarizations that occur in patients with malignant stroke, subarachnoid/intracranial hemorrhage, and traumatic brain injury are known to facilitate neuronal damage in metabolically compromised brain tissue. The dramatic failure of brain ion homeostasis caused by propagating spreading depolarizations results in neuronal and astroglial swelling. In essence, swelling is the initial response and a sign of the acute neuronal injury that follows if energy deprivation is maintained. Choosing spreading depolarizations as a target for therapeutic intervention, we have used human brain slices and in vivo real-time two-photon laser scanning microscopy in the mouse neocortex to study potentially useful therapeutics against spreading depolarization-induced injury. Methodology/Principal Findings: We have shown that anoxic or terminal depolarization, a spreading depolarization wave ignited in the ischemic core where neurons cannot repolarize, can be evoked in human slices from pediatric brains during simulated ischemia induced by oxygen/glucose deprivation or by exposure to ouabain. Changes in light transmittance (LT) tracked terminal depolarization in time and space. Though spreading depolarizations are notoriously difficult to block, terminal depolarization onset was delayed by dibucaine, a local amide anesthetic and sodium channel blocker. Remarkably, the occurrence of ouabain-induced terminal depolarization was delayed at a concentration of 1 μM that preserves synaptic function. Moreover, in vivo two-photon imaging in the penumbra revealed that, though spreading depolarizations did still occur, spreading depolarization-induced dendritic injury was inhibited by dibucaine administered intravenously at 2.5 mg/kg in a mouse stroke model. Conclusions/Significance: Dibucaine mitigated the effects of spreading depolarization at a concentration that could be well-tolerated therapeutically. Hence, dibucaine is a promising candidate to protect the brain from ischemic injury with an approach that does not rely on the complete abolishment of spreading depolarizations.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

e22351

Journal (Volume, Issue Number)

PloS one (Volume 6, Issue 7)

Publication milestones

  • Published - 2011

Publication status

Published - 2011

ISSN

1932-6203

Publication IDs

  • Scopus: 79960338590
  • PubMed: 21789251

Publication metrics

Metrics

SciVal
FWCI
0.52
SciVal
Author count
5
SciVal
citations
16
SciVal
Paper percentile
73
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
39
Citation count
27

Funding Details

FundersFunding numbers
NINDS
R01NS057113, R21NS062154, F31NS064753
UKRI
75675